StockWatch
·

SAMRAT PHARMACHEM LTD.-$ Q3 FY25 Results

SAMRATPHQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue63.669.3%
Total Income63.669.9%
Expenditure59.7511.0%
PBT3.9111.2%
Net Profit2.794.7%
OPM5.73%1.89pp
NPM4.37%0.60pp
EPS9.014.7%
View full financials

Informational and educational content only. Not investment advice.